Guangdong Celconta Biotechnology

Guangdong Celconta Biotechnology, also known as the Celconta Group or Xiankangda Bio, is a Chinese biopharmaceutical company specializing in the development and commercialization of advanced cell therapies. The company operates through several subsidiaries, including Celconta Life Science and Dongguan Life Bank, focusing on three main pillars: cell storage, drug development, and regenerative medicine. Celconta's R&D pipeline features innovative CAR-T and CAR-NK therapies targeting solid tumors, as well as mesenchymal stem cell treatments for degenerative diseases like osteoarthritis. With proprietary technology platforms such as Trans-CAR and Boost-CAR, the company is advancing multiple programs through clinical trials in collaboration with top-tier hospitals in China. Additionally, Celconta provides CDMO services and maintains a large-scale GMP-compliant manufacturing and storage infrastructure in the Songshan Lake High-Tech Zone.